Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 731

Whipple's Disease

Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644

New insights into the antiviral effects of chloroquine

Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570

Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 477

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century

Rolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 408

Initial study on SARS-CoV-2 main protease inhibition mechanism of some potential drugs using molecular docking simulation

Quân, P. M., Huong, L. T. T., Toàn, T. Q., Tung, N. S., Dan, N. T., Thủy, T. T. T., Cường, N. M., & Long, P. Q. (2020) · Vietnam Journal of Science and Technology/Science and Technology · doi:10.15625/2525-2518/58/5/14914 · Cited by 1

Reinforcing our defense or weakening the enemy? A comparative overview of defensive and offensive strategies developed to confront COVID-19

Khodajou-Masouleh, H., Shahangian, S. S., & Rasti, B. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1928686 · Cited by 1

Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment

Rezaei, Z., Mobasheri, L., & Sadri, F. (2021) · DNA and Cell Biology · doi:10.1089/dna.2021.0068 · Cited by 1

Acil Servise COVİD-19 Şüphesi ile Başvuran Bireylerin Hastalığa İlişkin Bilgilerinin İncelenmesi: Türkiye’nin Güneyi’nde Bir Pandemi Hastanesi Örneği

Eda, P. A. R. A., Uslu, Y., & Altınbaş, Y. (2021) · Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.46237/amusbfd.879110 · Cited by 1

Recent scientific research progress and challenges of COVID-19 pandemic: a global public health event

Hui, S. (2021) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-021-00058-x · Cited by 1

Telehealth and Pharmacological Strategies of COVID-19 Prevention: Current and Future Developments

Battineni, G., Nittari, G., Pallotta, G., Sagaro, G. G., Chintalapudi, N., & Amenta, F. (2021) · Studies in systems, decision and control · doi:10.1007/978-3-030-72834-2_26 · Cited by 1

In silicoDrug Repurposing for the Identification of Antimalarial Drugs as Candidate Inhibitors of SARS-CoV-2

Pasla, P. K., Thangaraju, P., Y, S. S. T., Sri Chandana, M., & Rizwaan Abbas, S. (2021) · Anti-Infective Agents · doi:10.2174/2211352519666211202141143 · Cited by 1

Awareness, Knowledge, and Perceptions of COVID-19 Precautions Among Employees of Al-Imam Abdulrahman Al Faisal Hospital in Riyadh, KSA

Alqarni, A. M., Bajahzer, M., Asseri, M., Alahmari, A. S., Alkhaldi, S., Bantun, F., & Alhamoud, A. H. (2022) · Cureus · doi:10.7759/cureus.25918 · Cited by 1

BIOORGANOMETALLIC FERROQUINE AND RELATED COMPOUNDS AS ANTIMALARIAL CHEMOTHERAPEUTIC AGENTS: A SHORT REVIEW

Abubakar, T. A., Eke, U. B., & Salisu, A. (2022) · Journal of Chemical Society of Nigeria · doi:10.46602/jcsn.v47i3.758 · Cited by 1

Quinone and SARS-CoV-2

Hussain, F., Nawaz, M. N., Rahim, K., Sahar, H. S., Adnan, M., & Nisar, M. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95047-3.00008-3 · Cited by 1

Du Médiator à l’hydroxychloroquine, les cent visages des scandales du médicament

Chast, F. (2022) · Raison présente · doi:10.3917/rpre.223.0195 · Cited by 1

The Role of Hyaluronic Acid in Tissue Engineering

Collins, M. N., Zamboni, F., Serafin, A., Ren, G., Thanusha, A. V., & Culebras, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-35734-4_56-1 · Cited by 1

Cartas na epidemia: escritas de resistência

Meneghel, S. N. (2023) · Athenea Digital Revista de pensamiento e investigación social · doi:10.5565/rev/athenea.3223 · Cited by 1

Application of Virtual Screening and Molecular Modeling Technologies to Identify Potential SARS-CoV-2 Main Protease Inhibitors

Andrianov, A. M., Furs, K. V., Gonchar, A. V., Aslanyan, L. H., & Tuzikov, A. V. (2023) · Mathematical Biology and Bioinformatics · doi:10.17537/2023.18.15 · Cited by 1

The importance of outpatient etiotropic therapy in patients hospitalized with COVID-19

Zhanibekov, Z. Z., Chukhliaev, P. V., Александровна, Х. Д., Ахмедова, М. Д., & Ruzhentsova, T. A. (2023) · Journal Infectology · doi:10.22625/2072-6732-2023-15-1-48-54 · Cited by 1

Investigation of Tablet Defects by AI Based Terahertz Technology

Yadav, N. P., Hu, G., & Singh, R. K. (2023) · Open Journal of Antennas and Propagation · doi:10.4236/ojapr.2023.112003 · Cited by 1

"Insilico Identification and Exploring the Potential Hits to Combat SARS-CoV-2 RDRP"

Zheng, G. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.48.007721 · Cited by 1

Nanotechnological strategies for drug delivery and treatment of COVID-19

Ingle, A. P., Gade, A., Bonde, S., Wypij, M., Golińska, P., & Rai, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91763-6.00013-8 · Cited by 1

Social Media and Digital Politics

Lee, J., & Blevins, J. L. (2024) · Routledge eBooks · doi:10.4324/9781003386377 · Cited by 1

In-silico Screening of Natural Compound Library against COVID-19 Main Protease

Nag, M., Paul, R. K., Dasgupta, D., Yakin, J., Biswas, S., Chattopadhyay, S., Bora, R., & Alam, F. (2024) · Anti-Infective Agents · doi:10.2174/0122113525310221240713022605 · Cited by 1

COVID 19 opciones terapeuticas desde la viro-patogenesis a la evidencia clinica

González, J., & González, A. (2020) · Revista Colombiana de Nefrología · doi:10.22265/acnef.7.supl.2.433 · Cited by 1

Severe Acute Respiratory Syndrome Coronavirus 2: Genomic Observations and Emerging Therapies

Dehority, W. N., Spence, D., & Dinwiddie, D. L. (2020) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2020.1179 · Cited by 1

The COVID ‐19 chemoprophylactic conundrum: Are we limiting available resources?

Sharma, A., Mhatre, M., Goldust, M., Jindal, V., & Singla, P. (2020) · Dermatologic Therapy · doi:10.1111/dth.13607 · Cited by 1

SARS – COV-2 (COVID-19) Pandemic: A Critical Review on Novel Coronavirus Pathogenesis, Clinical Diagnosis and Treatment

Jain, R., Jain, N. K., Jain, S., & Dhakar, R. C. (2020) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v10i3.3985 · Cited by 1

COVID-19: What we all intensivists should know

Jha, S. K., Behera, S. K., Singh, N., Khilnani, G. C., Mahajan, A., Kumar, S., Kumar, A., & Sant, S. (2020) · Saudi Critical Care Journal · doi:10.4103/sccj.sccj_16_20 · Cited by 1

Artemisinin and its Derivatives as Repurposing Drug against COVID-19

Kumari, K., & Mishra, S. K. (2020) · Acta Scientific Cancer Biology · doi:10.31080/ascb.2020.04.0237

A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2

Musca, S. C. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00490 · Cited by 1

COVID-19 detection: Comparison and accuracy of several diagnostic tests

Ullah, M., Ibrar, M., Khan, S. U., Ullah, H., & Khan, N. A. (2020) · Novel Research in Microbiology Journal · doi:10.21608/nrmj.2020.107539 · Cited by 1

A Review on Acute Respiratory Syndrome Corona Virus 2 (SARS-Cov-2) & Its Preventive Management

Singh, V. A. (2020) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v8i3.723 · Cited by 1

A Review on 2019-nCoV (SARS-CoV-2) in India

Mahawar, P. K., & Sharma, A. (2020) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v8i3.744 · Cited by 1

Análise “in silico” da hidroxicloroquina e de compostos obtidos através de sua modificação molecular

Ribeiro, J. M., Sousa, W. F. C., & de Sousa, J. A. (2020) · Research Society and Development · doi:10.33448/rsd-v9i9.7359 · Cited by 1

O SARS-CoV-2 e a prática odontológica

Gatis, M. C. D. Q., Barbosa, L. M., Monteiro, J. L. G. C., Sampaio, T. R. D. C., Filho, J. B. H. C., & Vasconcelos, B. C. D. E. (2020) · Research Society and Development · doi:10.33448/rsd-v9i9.7884 · Cited by 1

The Origin, Transmission, and Clinical Therapies in the Management of Coronavirus Diseases

Kaka, N., Pal, A., Abdul-Fattah, S., & Kakodkar, P. (2020) · Methods in pharmacology and toxicology · doi:10.1007/7653_2020_45 · Cited by 1

Arrhythmias and COVID-19 infection

Chin, A., Moses, J., & Thornton, A. (2020) · SA Heart · doi:10.24170/17-3-4384 · Cited by 1

The clinical manifestations and interval changes of reverse-transcriptase quantitative polymerase chain reactions among different specimens of coronavirus disease 2019 patients

Chen, P.-L., Hsiao, Y., Chuang, C., Feng, J., Ho, H., Lin, Y.-T., Chen, S., Huang, S., Chen, H., Chou, T., et al. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000451 · Cited by 1

Development of research on COVID-19 by the World Scientific Community in the first half of 2020

Tinôco, D., & Borschiver, S. (2020) · Bionatura · doi:10.21931/rb/2020.05.04.23 · Cited by 1

Mães adolescentes: Direito à escolarização durante hospitalização do filho na UTI neonatal

Mozeléski, D. R. D. S., da Silva, L. C. S., & Basso, R. M. F. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.08 · Cited by 1

A eficácia dos testes clínicos de campo na avaliação da capacidade funcional dos pacientes com DPOC: Uma revisão de literatura

Gonçalves, L. D. A., dos Santos, D. M., de Moraes, A. A., & leite, B. R. A. F. D. B. (2020) · Editora Poisson eBooks · doi:10.36229/978-65-5866-037-8.cap.20 · Cited by 1

Evidence-Based Progressive Passage to Reopening American Societies Post COVID-19

Daoud, Z., McLeod, J., Ikpatt, O. F., Perez, M., Atkins, M., SPeyer, T., & Stockman, D. L. (2020) · The International Arabic Journal of Antimicrobial Agents · doi:10.3823/850 · Cited by 1

Potential Therapeutic Approaches for SARS CoV2 Infection

Devasena, T. (2021) · SpringerBriefs in applied sciences and technology · doi:10.1007/978-981-33-6300-7_6 · Cited by 1

COVID-19 Tedavisine Yönelik Guncel Farmakolojik Yaklaşımlar

Eroglu, E., Balcı, H., Baskin, V., & Aktuna, Z. (2021) · Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi · doi:10.51261/yiu.2021.00018 · Cited by 1

Customized Data Extraction and Effective Text Data Preprocessing Technique for Hydroxychloroquin Related Twitter Data

Priya, K. (2020) · Bioscience Biotechnology Research Communications · doi:10.21786/bbrc/13.13/21 · Cited by 1

A Therapeutic Journey of Potential Drugs Against COVID-19

Ali, F., Zhu, Y. Z., & Hussain, S. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210412161157 · Cited by 1

Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases

Yu, Y., Xu, J., Xie, A., Liu, S., Wang, X., Zhu, R.-Z., & Wang, X. (2021) · Kidney Diseases · doi:10.1159/000515278 · Cited by 1

Repurposed Drugs as a Ray of Hope for COVID-19 Patients

Jawed, A., Parveen, R., Dar, S. A., Haque, S., Mandal, R. K., Akhter, N., Areeshi, M. Y., Lohani, M., Rabaan, A. A., & Wahid, M. (2021) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2021.04.0830 · Cited by 1

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial

Rahimi, H., Allahyari, A., Azimi, S. A., Kamandi, M., Mozaheb, Z., Zemorshidi, F., Khadem‐Rezaiyan, M., Bary, A., Seddigh‐Shamsi, M., & Nodeh, M. M. (2021) · Trials · doi:10.1186/s13063-021-05292-8 · Cited by 1

Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis

Arfaras-Melainis, A., Tzoumas, A., Kokkinidis, D. G., Guerrero, M. S., Varrias, D., Xu, X., Cerna, L. E., Avendaño, R., Kemal, C., Palaiodimos, L., et al. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8050055 · Cited by 1

The use of Tisdale risk score during hydroxychloroquine/chloroquine treatments on COVID-19 patients

Hartopo, A. B., Trisnawati, I., Budiono, E., Jhundy, B. W., & Anggraeni, V. Y. (2021) · ACI (Acta Cardiologia Indonesiana) · doi:10.22146/jaci.v7i1.1208 · Cited by 1

Insights into COVID-19 Chemotherapies: Potential and Challenges

Yahya, E. B. (2021) · Journal of Chemistry and Nutritional Biochemistry · doi:10.48185/jcnb.v2i1.168 · Cited by 1

Cardiac anesthesia in the time of coronavirus disease 2019: an Egyptian experience using a case series

Said, A. M., & Salah, M. (2021) · The Egyptian Journal of Cardiothoracic Anesthesia · doi:10.4103/ejca.ejca_26_20 · Cited by 1

Forty‐fifth ASPEN Presidential Address: Research in a pandemic—Why, what, how?

Rice, T. W. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2261

Effects of COVID-19 Infection on P-Wave Dispersion, P-Wave Peak Time and Atrial Conduction Times

Boyraz, B., & İbişoğlu, E. (2021) · e-Journal of Cardiovascular Medicine · doi:10.32596/ejcm.galenos.2021-05-033 · Cited by 1

A review of the First Outbreak of the 2019 Novel Coronaviruses (SARS-CoV-2, COVID-19) in Egypt

Abumandour, M. M. A., Madkour, N., Tawfik, R. G., & Abumandour, R. M. (2021) · Journal of Morphological Sciences · doi:10.51929/jms.38.45.2021 · Cited by 1

ACOMPANHAMENTO FARMACOTERAPÊUTICO A USUÁRIOS DE HIDROXICLOROQUINA PARA O TRATAMENTO DO COVID-19

da Cunha, K. T. L., Diniz, J. S., Neto, M. P. L., & de Assunção, W. G. (2021) · Anais do 2º CONGRESSO BRASILEIRO CIÊNCIA E SOCIEDADE · doi:10.17648/cbcs-2021-137927 · Cited by 1

Combatting SARS-CoV-2: Potential Therapeutic Candidates Against COVID-19

Gupta, P. K., & Kulkarn, S. (2021) · EMJ Allergy & Immunology · doi:10.33590/emjallergyimmunol/21-00088 · Cited by 1

A Review on Hydroxychloroquine Drug: to Combat COVID-19

(2020) · Letters in Applied NanoBioScience · doi:10.33263/lianbs94.17051716 · Cited by 1

Processes for the synthesis of γ-acetopropyl alcohol

Tarabanko, V. E., Смирнова, М. А., & Zhizhina, E. G. (2022) · Kataliz v promyshlennosti · doi:10.18412/1816-0387-2022-2-5-17 · Cited by 1

Ключові ланки патогенезу легеневої недостатності при COVID-19 та шляхи фармакокорекції

Лук’янчук, В. Д., Гордійчук, Д. О., & Shevchuk, O. O. (2022) · Bulletin Of Medical And Biological Research · doi:10.11603/bmbr.2706-6290.2022.2.13082 · Cited by 1

Management of acute COVID-19 in the pediatric population and role of antimicrobial therapy

Groves, H. E., Allen, U., & Morris, S. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95059-6.00006-1 · Cited by 1

Bacteriophage and nanotechnology in the management of COVID-19: A Review Article

Zghair, A., & Kasim, C. (2022) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/v9i2.900 · Cited by 1

Protocolo de manejo pacientes Covid-19 hospitalizados en sala (junio del 2020)

Gonzalo Díaz, V. (2020) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2020.69904 · Cited by 1

Low-dimensional compounds containing bioactive ligands. XXII. First crystal structure, cytotoxic activity and DNA and HSA binding of a zirconium(IV) complex with 8-hydroxyquinoline-2-carboxylic acid

Harmošová, M., Vilková, M., Kello, M., Smolko, L., Samoľová, E., Šebová, D., & Potočňák, I. (2023) · Acta Crystallographica Section C Structural Chemistry · doi:10.1107/s2053229623005971 · Cited by 1

COVID-19; Systematic and literature review of transmission, case definitions, clinical management and clinical trials.Preprint

McArthur, L., Sakthivel, D., Ataíde, R., Chan, F., Richards, J. S., & Narh, C. A. (2020) · medRxiv · doi:10.1101/2020.05.14.20102475 · Cited by 1

Approaches Towards Fighting COVID-19 in TaiwanPreprint

Tsai, S. C., Bau, D.-T., Chiu, Y., Yen, Y.-T., Hsu, Y., Fu, C., Kuo, S., Lo, Y., Chiu, H., Juan, Y., et al. (2020) · doi:10.22541/au.159007748.88776078

Visualization analysis of the characteristics of COVID-19 clinical trialPreprint

Cai, X.-Q., Zheng, Z., Su, Q., & Huang, J. (2020) · doi:10.21203/rs.3.rs-21472/v1 · Cited by 1

Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in LebanonPreprint

Chamieh, A., Afif, C., Hajj, G. E., Zmerli, O., Djaffar-Jureidini, I., Raad, R. A., Ashou, R., Juvelekian, G. S., Rolain, J., & Azar, E. (2020) · medRxiv · doi:10.1101/2020.05.28.20114835 · Cited by 1

Febuxostat as an alternative therapy in COVID-19: A double-blind randomized clinical trialPreprint

Davoodi, L., Abedi, S. M., Salehifar, E., Alizadeh-Navai, R., Rouhanizadeh, H., Khorasani, G., & Hosseinimehr, S. J. (2020) · doi:10.22541/au.159007758.87901715 · Cited by 1

In-Silico Interaction of Hydroxychloroquine Drug with Various Proteins of Coronavirus (SARS-CoV-2): A Computational Approaches to Combat COVID-19Preprint

Kalaria, R. K., & Patel, H. K. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12470381.v1 · Cited by 1

COVID-19: Recent Findings into Emerging CoronavirusPreprint

Hezam, K., Almansoub, H. A. M. M., Saleh, F., Almansob, Y. A. M., Al‐Mekhlafi, H., Al-Yousofi, A., Al-Gheethi, A. A. S., Almezgagi, M., Al‐Shaebi, F., & Murshed, D. (2020) · Preprints.org · doi:10.20944/preprints202006.0157.v1

Anti-inflammatory, immunomodulatory agents as potential strategies against COVID-19: A systematic reviewPreprint

Sinaei, R., Pezeshki, S., Sinaei, A., & Sinaei, A. (2020) · doi:10.22541/au.159242078.89654740 · Cited by 1

Targeted Population, Strategy, Issues and Progress to Combat COVID-19Preprint

saini, D., Rai, N., Jha, P., & Jha, M. (2020) · Preprints.org · doi:10.20944/preprints202009.0002.v1 · Cited by 1

Screening of Anticancer Drugs as Potential Candidates to Target COVID-19 DiseasePreprint

Gurjar, G. S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12277046.v1 · Cited by 1

Summary of the clinical manifestations, infection mechanisms and current drug treatment of SARS-CoV-2 infectionPreprint

Qin, F., Hong, W., Cheng, Y., Li, X., Wang, Y., Liu, J., & Wei, X. (2020) · doi:10.22541/au.159969697.74833043 · Cited by 1

Therapeutic Preferences for Coronavirus 2(SARS-CoV-2) PatientsPreprint

Mustafa, N. (2020) · doi:10.21203/rs.3.rs-19507/v1 · Cited by 1

SARS - CoV - 2 Attachment to Host Cells is Possibly Mediated via RGD - Inte grin Interaction in a Calcium - dependent MannerPreprint

Dakal, T. C. (2020) · doi:10.31219/osf.io/chvsa · Cited by 1

COVID19 PANDEMIC: WHY DOES IT HAPPEN AND WHERE DOES IT TAKE US TO?Preprint

Klokol, D., Nallenthiran, L., Nalapko, Y., & Papacharalampous, M. (2020) · doi:10.31219/osf.io/dbe52 · Cited by 1

In-Silico Interaction of Hydroxychloroquine Drug with Various Proteins of Coronavirus (SARS-CoV-2): A Computational Approaches to Combat COVID-19Preprint

Kalaria, R. K., & Patel, H. K. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12470381 · Cited by 1

Potential Drug Targets and Treatment Options for Covid-19: A ReviewPreprint

Wubetu, M. (2022) · Preprints.org · doi:10.20944/preprints202208.0212.v1

Low-Dimensional Compounds Containing Bioactive Ligands. Part Xxiii: A Comprehensive Study of the Preparation and Cytotoxic Activities of Zirconium(IV) Complexes with 8-Hydroxyquinoline and its DerivativesPreprint

Harmošová, M., Vilková, M., Kello, M., Šebová, D., Samoľová, E., Litecká, M., & Potočňák, I. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4461808 · Cited by 1

Coronavirus disease 2019: Lessons, risks and challenges

Richards, G. A., & Stacey, S. L. (2020) · African Journal of Thoracic and Critical Care Medicine · doi:10.7196/ajtccm.2020.v26i2.068

Chloroquine Administration in Breastfeeding Mothers Associates with Increased HIV-1 Plasma Viral LoadsPreprint

Paxton, W. A., Naarding, M. A., Wit, F. W. N. M., Veldhuijzen, N. J., Chersich, M., Kankindi, B., Douma, R. A., Tuyizere, S., Jurriaans, S., Sparidans, R. W., et al. (2020) · medRxiv · doi:10.1101/2020.04.29.20085308

Neonatologists’ Challenges During COVID-19 Pandemic

Al‐lawama, M. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4146

COVID-19 LITERATURE DATA ANALYSIS, CURRENT DATA AND MEDICINAL PLANTS (Case of Morocco) – Review Article

Zineb, J., Lyoussi, B., & Lamrhari, H. (2020) · Journal of Bio Innovation · doi:10.46344/jbino.2020.v09i03.01

Energy dynamics for systemic configurations of virus-host co-evolutionPreprint

Romano, A., Casazza, M., & Gonella, F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.13.092866

Pregnancy in Coronavirus Disease (COVID-19) Pandemic: Clinical Opinion

Alhubaishi, L. Y. A., & Fazari, A. B. (2020) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2020.1050064

Eruption of COVID-19 like illness in a remote village in Papua (Indonesia)Preprint

van Burg, E., & van Burg-Verhage, W. (2020) · medRxiv · doi:10.1101/2020.05.19.20106740

Six Critically Ill COVID-19 Pregnant Patients at a Detroit Hospital: A Case SeriesPreprint

Smith, N., Hong, L. A., Keerthy, M., Lee-Griffith, M., Garcia, R., Shaman, M., & Goyert, G. L. (2020) · doi:10.22541/au.159103653.39532576

A systematic review protocol of the antiviral activity of chloroquine and hydroxychloroquine against COVID-19Preprint

Mensah, K. B., Mensah, A. B. B., Bangalee, V., & Oosthuizen, F. (2020) · medRxiv · doi:10.1101/2020.06.13.20130245

CORONAVÍRUS E SUA PROTEASE PRINCIPAL: UMA VISÃO PARA O PLANEJAMENTO DE FÁRMACOS POR DOCAGEM MOLECULAR

Gonçalves, S. Q. B., Filho, E. A. D. S., de Oliveira, O. V., & Gonçalves, A. D. S. (2020) · Revista Ifes Ciência · doi:10.36524/ric.v6i1.626

Recomendaciones para reumatólogos sobre el manejo farmacológico durante la emergencia sanitaria por COVID-19: opinión de un grupo de expertos

López, J.-G., Barbosa, J. C. C., Felipe-Díaz, O. J., Rojas-Zuleta, W. G., Ballesteros, J.-G., Navarro-Mendoza, E., Herrera, C.-L. G., Giraldo, R. B., Padilla-Tovar, L., Duque-Zapata, N., et al. (2020) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2020.05.021

A Perspective Approach Of Hydroxychloroquine In The Treatment for Covid-19

Chandrasekar, S., & Muthusamy, G. (2020) · American Journal Of Pharmacy And Health Research · doi:10.46624/ajphr.2020.v8.i6.004

Insight on Novel-COVID-19- A review

Sarma, A., & Halder, N. (2020) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.2020.015

Pregnancy Treatment in Covid-19 Pandemic: General Considerations

Santana, E. F. M. (2020) · World Journal of Gynecology & Womens Health · doi:10.33552/wjgwh.2020.03.000571

De l’omelette de Condorcet à la nécessaire collaboration entre disciplines scientifiques à l’ère de la COVID-19

Gauld, C., & Micoulaud‐Franchi, J. (2020) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2020.06.006

Derived telemetry-based electrocardiograms in the intensive care unit: insights from a COVID-19 epicenterPreprint

Coromilas, E. J., Pugliese, D. N., Kochav, S. M., Yarmohammadi, H., Wan, E. Y., & Dizon, J. M. (2020) · doi:10.22541/au.159181121.14843689

Covid 19, the Kerala experience: an observational, single centre retrospective study of outcome in covid positive pregnancies

Nambiar, S. S., Ajith, S., & Reshmi, V. P. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20203289

A Comprehensive review on genomic diversity and epidemiology of COVID-19

Raza, Z. H., Ihsan, M. A., Sahrish, K., Zafar, H., & Tayyaba, R. (2020) · International Journal of Clinical Virology · doi:10.29328/journal.ijcv.1001021

Review on clinical features of Covid-19 OutbreakPreprint

Ain, N. U. (2020) · doi:10.22541/au.159593980.05145087

Effects of Aminoquinolines in COVID-19 Treatment: Hydroxychloroquine and Chloroquine

Ishaq, A., Aminu, U., & Muhammad, F. (2020) · Annals of Military and Health Sciences Research · doi:10.5812/amh.106658

Human Immune Response to COVID-19 Infection and Potential Role of Chloroquine Family of DrugsPreprint

Singh, S., Chandrashekharaiah, P. S., Paul, V., Kodgire, S., Kushwaha, S., Sanyal, D., & Dasgupta, S. (2020) · doi:10.21467/preprints.201

Can we use hydroxychloroquine to treat COVID-19 now?

Chen, J., Liu, D., Yin, L., Zhang, L., & Lu, H. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106173 · Cited by 1

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine

Sahraei, Z., Shabani, M., Shokouhi, S., & Saffaei, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105945 · Cited by 234

Chloroquine and hydroxychloroquine as potential therapies against COVID-19

Yewange, S., Deshpande, R. R., Waghmare, N., Vidyasagar, G., Bavage, S. B., & Bavage, N. B. (2020) · Cited by 1

Chloroquine as a prophylactic agent against COVID-19?

Gendrot, M., Javelle, É., Clerc, A., Savini, H., & Pradines, B. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105980 · Cited by 44

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471